# [14C] Mass Balance Clinical Trial of Azvudine in Healthy Male Subjects

> **NCT07002281** · PHASE1 · COMPLETED · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]Azvudine suspension

## Key facts

- **NCT ID:** NCT07002281
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-22
- **Primary completion:** 2024-10-10
- **Final completion:** 2025-03-20
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002281, "[14C] Mass Balance Clinical Trial of Azvudine in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07002281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*